1. IL‐17 and TNF‐α co‐operation contributes to the proinflammatory response of hepatic stellate cells. (6th June 2019) Authors: Beringer, A.; Miossec, P. Journal: Clinical and experimental immunology Issue: Volume 198:Number 1(2019) Page Start: 111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Role of podoplanin in the high interleukin‐17A secretion resulting from interactions between activated lymphocytes and psoriatic skin‐derived mesenchymal cells. (9th August 2016) Authors: Noack, M.; Ndongo‐Thiam, N'D.; Miossec, P. Journal: Clinical and experimental immunology Issue: Volume 186:Number 1(2016:Oct.) Page Start: 64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SAT0052 TNFγ adherent BM-DC efficiently inhibit collagen-induced- arthritis, and delayed skin graft rejection in mouse. (23rd January 2014) Authors: Brikci-Nigassa, L.; Touraine, J.-L.; Miossec, P.; Eljaafari, A. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 488 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SAT0132 Severe periodontal disease associated with severe rheumatoid arthritis is a predictive factor for clinical infliximab response. (23rd January 2014) Authors: Marotte, H.; Miossec, P.; Grange, L.; Pallot-Prades, B.; Gaudin, P.; Thomas, T. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 515 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Synergistic effect of interleukin‐17 and tumour necrosis factor‐α on inflammatory response in hepatocytes through interleukin‐6‐dependent and independent pathways. (31st May 2018) Authors: Beringer, A.; Thiam, N.; Molle, J.; Bartosch, B.; Miossec, P. Journal: Clinical and experimental immunology Issue: Volume 193:Number 2(2018:Aug.) Page Start: 221 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. THU0099 Monitoring of abatacept in rheumatoid arthritis patients with previous failure to biotherapies suggests that CTLA-4/CD3E and/or CD28/CTLA-4 MRNA ratio may predict response to treatment at 3 months. (23rd January 2014) Authors: Eljaafari, A.; Tartelin, M.-L.; Aissaoui, H.; Miossec, P. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 187 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. THU0154 Biomarker Sets PREDICT Therapeutic Response to Tnf-Inhibitors in Rheumatoid Arthritis and Spondyloarthritis Patients: A Theragnostic Approach in A Multicenter Cohort. (10th June 2014) Authors: Baillet, A.; Trocmé, C.; Marotte, H.; Soubrier, M.; Tébib, J.; Thomas, T.; Miossec, P.; Pellot-Prades, B.; Grange, L.; Toussaint, B.; Juvin, R.; Morel, F.; Drouet, C.; Gaudin, P. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗